Clinical outcomes of children with rheumatic heart disease.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
04 2022
Historique:
received: 23 09 2021
accepted: 19 01 2022
pubmed: 4 2 2022
medline: 30 4 2022
entrez: 3 2 2022
Statut: ppublish

Résumé

To evaluate the long-term clinical outcomes of children with rheumatic heart disease (RHD) in Uganda, and determine characteristics that predict adverse outcomes. This retrospective cohort study evaluated the risk of death in Ugandan children with clinical RHD from 2010 to 2018; enrolling children aged 5-18 years old from an existing registry. Demographic data and clinical data (baseline complications, RHD severity, cardiac interventions) were collected. The primary outcome was survival. Univariable and multivariable hazard ratios (HR) were obtained from Cox proportional hazards regression. Survival probabilities were developed using Kaplan-Meier curves; log-rank tests compared survival based on cardiac interventions, disease severity and time of enrolment. 612 cases met inclusion criteria; median age 12.8 years (IQR 5.3), 37% were male. Thirty-one per cent (187 of 612) died during the study period; median time to death 7.8 months (IQR 18.3). In univariable analysis, older age (HR 1.26, 95% CI=1.0 to 1.58), presence of baseline complications (HR 2.06, 95% CI=1.53 to 2.78) and severe RHD (HR 5.21, 95% CI=2.15 to 12.65) were associated with mortality. Cardiac intervention was associated with a lower risk of mortality (HR 0.06, 95% CI=0.02 to 0.24). In multivariable models, baseline complications (HR 1.78, 95% CI=1.31 to 2.41), severe RHD (HR 4.58, 95% CI=1.87 to 11.23) and having an intervention (HR 0.05, 95% CI=0.01 to 0.21) remained statistically significant. Kaplan-Meier survival curves demonstrated >25% mortality in the first 30 months, with significant differences in mortality based on intervention status and severity of disease. The mortality rate of children with clinical RHD in Uganda exceeds 30%, over an 8-year time frame, despite in-country access to cardiac interventions. Children at highest risk were those with cardiac complications at baseline and severe RHD.

Identifiants

pubmed: 35110387
pii: heartjnl-2021-320356
doi: 10.1136/heartjnl-2021-320356
pmc: PMC9221000
mid: NIHMS1814551
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

633-638

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Circulation. 2016 Nov 8;134(19):1456-1466
pubmed: 27702773
BMC Cardiovasc Disord. 2017 Jan 7;17(1):20
pubmed: 28061759
Circulation. 2017 Dec 5;136(23):2233-2244
pubmed: 28972003
Heart Asia. 2019 Jun 20;11(2):e011191
pubmed: 31297163
Heart. 2019 Jan;105(1):60-66
pubmed: 30068532
Heart Asia. 2018 Jan 13;10(1):e010981
pubmed: 29422951
Heart. 2016 Jan;102(1):35-9
pubmed: 26438784
Eur Heart J. 2015 May 7;36(18):1115-22a
pubmed: 25425448
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Glob Heart. 2018 Dec;13(4):293-303
pubmed: 30245177
Int J Cardiol. 2017 Aug 1;240:422-427
pubmed: 28400121
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
Circulation. 2012 Jun 26;125(25):3127-32
pubmed: 22626741
Glob Heart. 2021 Feb 09;16(1):11
pubmed: 33598391
Ann Pediatr Cardiol. 2017 Jan-Apr;10(1):50-57
pubmed: 28163428

Auteurs

Meghan Zimmerman (M)

Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA meghan.s.zimmerman@hitchcock.org.
Dartmouth College Geisel School of Medicine, Hanover, New Hampshire, USA.

Samalie Kitooleko (S)

Cardiology, Uganda Heart Institute, Kampala, Uganda.

Emmy Okello (E)

Cardiology, Uganda Heart Institute, Kampala, Uganda.
Makerere University, Kampala, Uganda.

Nicholas Ollberding (N)

Rehabilitation, Exercise, and Nutrition Sciences, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Pranava Sinha (P)

The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Pediatric Cardiology, Children's National Hospital, Washington, District of Columbia, USA.

Tom Mwambu (T)

Cardiology, Uganda Heart Institute, Kampala, Uganda.
Makerere University, Kampala, Uganda.

Craig Sable (C)

The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Pediatric Cardiology, Children's National Hospital, Washington, District of Columbia, USA.

Andrea Beaton (A)

University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Pediatric Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Chris Longenecker (C)

Cardiovascular Medicine, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Peter Lwabi (P)

Cardiology, Uganda Heart Institute, Kampala, Uganda.
Makerere University, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH